Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology News Journal.
Press releases published on June 9, 2025

Outbrain Completes Change of Corporate Name to Teads
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ: OB), which is operating under the new Teads brand following Outbrain’s acquisition of Teads in February 2025, announced today that the combined company has completed its corporate renaming …

Oddity Finance LLC Announces Proposed $350 Million Offering of 0% Exchangeable Senior Notes Due 2030
As of March 31, 2025, ODDITY had $257 million in cash, and an undrawn $200 million credit line Capital raise gives ODDITY additional firepower to play offense and pursue future opportunities in a volatile world A portion of the proceeds will be used to …

George Medicines announces FDA approval of WIDAPLIK™ (telmisartan, amlodipine and indapamide), a new single pill combination treatment for hypertension in adults, including initial treatment
Novel, single pill, triple combination with a standard dose and two lower doses that can deliver the efficacy benefits of combination therapy, with an established safety profile and good tolerability First and only triple combination for the initial …

Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum
HOUSTON, June 09, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (OTC:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer and obesity …

G2 Drills Multiple Near Surface Intercepts in New Oko Discovery Area, Significant Sulphide Mineralization Encountered in Deeper Drill Holes
Hole AMD18 returns 65m @ 1.5 g/t Au & 9.7m @ 3.1 g/t Au Hole AMD23 returns 52m @ 0.9 g/t Au Hole AMD25 intercepts 70.5m @ 1.8 g/t Au New Oko discovery total strike length of 630m; remains open in all directions TORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- G2 …

NewAmsterdam Pharma Announces Positive Topline Alzheimer’s Disease Data from BROADWAY Clinical Trial
-- Pre-specified analyses show that obicetrapib treatment leads to statistically significant and clinically meaningful reductions in the primary outcome measure of Alzheimer’s disease biomarker in both the full ITT population (p<0.002) and in ApoE4 …

Secura Bio Announces First Patient Dosed in Phase 3 TERZO Study of COPIKTRA® (duvelisib) in Relapsed/Refractory Nodal T-follicular Helper Cell Lymphoma
SUMMERLIN, Nev., June 09, 2025 (GLOBE NEWSWIRE) -- Secura Bio, Inc. (www.securabio.com), an integrated pharmaceutical company maximizing commercial outcomes for oncology medicines, today announced that the first patient has been dosed in its Phase 3 TERZO …

Sagimet Biosciences to Host Virtual KOL Event, “A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne” on June 16, 2025
SAN MATEO, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced it will host a …

IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, announced that Patient 009 in the Phase 1 trial of …

New Report Reveals Canadian Men Are Dying Too Young
TORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Movember – the world’s leading men’s health charity – has released the Real Face of Men’s Health Report (the report) detailing new findings on the state of men’s health in Canada. The report reveals that more than …

Un nouveau rapport révèle que les hommes canadiens meurent trop jeunes
TORONTO, 09 juin 2025 (GLOBE NEWSWIRE) -- Movember, le plus important organisme caritatif mondial dédié à la santé masculine, a publié le rapport intitulé Le vrai visage de la santé masculine, qui présente les nouvelles conclusions sur l'état de la santé …

Axsome Therapeutics Provides Update on the New Drug Application (NDA) for AXS-14 for the Management of Fibromyalgia
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it has received a Refusal to File (RTF) letter …

Jupiter Neurosciences Launches Nugevia™: A Premium Longevity and Performance Supplement Line Grounded in Clinical Science
First consumer products roll out in Q3 2025, creating near-term revenue potential and marking a new chapter in Jupiter's evolution Jupiter, Florida, June 09, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), …

Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy
Preclinical data highlighted JADE101’s femtomolar APRIL binding affinity, extended non-human primate half-life of approximately 27 days, and sustained IgA suppression In non-human primates, JADE101 showed a differentiated pharmacokinetic and …

TransCon® hGH Boosted Treatment Benefits of TransCon® CNP in Children with Achondroplasia at Week 26 Interim Analysis of the Phase 2 COACH Trial
- For the TransCon CNP treatment-naïve cohort, combination treatment resulted in mean annualized growth velocity (AGV) of 9.14 cm/year, with an improvement in mean ACH height Z-score of +0.53 over 26 weeks - For the TransCon CNP-treated cohort, combination …

Keros Announces Return of $375 Million in Excess Capital to Stockholders
LEXINGTON, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of …

Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for May 2025 of its Virtune Crypto Altcoin Index ETP
Stockholm, 9th of June 2025 – Virtune AB (Publ) ("Virtune") today announces that it has completed the monthly rebalancing of the Virtune Crypto Altcoin Index ETP, listed on Nasdaq Stockholm and Nasdaq Helsinki (ISIN code SE0023260716). In addition to the …

Virtune AB (Publ) ("Virtune") har genomfört den månatliga rebalanseringen för maj 2025 av Virtune Crypto Altcoin Index ETP
Stockholm, 9 juni 2025 – Virtune meddelar idag att man har slutfört den månatliga rebalanseringen av Virtune Crypto Altcoin Index ETP, noterad på Nasdaq Stockholm och Nasdaq Helsinki (ISIN-kod SE0023260716). Utöver Virtune Crypto Altcoin Index ETP omfattar …
![[Latest] Global Prepaid Gift Card Market Size/Share Worth USD 5.41 Billion by 2034 at a 7.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](/images/pressrelease-small.png)
[Latest] Global Prepaid Gift Card Market Size/Share Worth USD 5.41 Billion by 2034 at a 7.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Austin, TX, USA, June 09, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Prepaid Gift Card Market Size, Trends and Insights By Offering Type (General Purpose Reloadable Card, Gift Cards, Incentive/Payroll Card, …

Quid Miner's new application dominated the hot search list as soon as it was launched
Houston, TX, June 09, 2025 (GLOBE NEWSWIRE) -- Quid Miner recently launched a new mobile app: allowing users to mine easily anytime and anywhere. As a green cloud mining platform established legally and compliantly in the UK. It provides mining services …